Skip to main content

Table 1 The expression level of TET1 in different malignant diseases and subtypes

From: Advances in the DNA methylation hydroxylase TET1

Malignant Diseases

Subtypes

Expression Level of TET1

Leukemia

AML

Low

T-ALL

High

Breast Cancer

HER2

Unchanged

HRBC

Low

Triple Negative

High

Lung Cancer

Adenocarcinoma

High

Squamous Cell Carcinoma

High

Hepatocellular Carcinoma

Low

Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

Low

Colon Cancer

Low

Pancreatic Cancer

Low

Prostate Cancer

Low

Cervical Cancer

High